RxDoctor Payments Data

Janna Goldfeld

Physician Assistant · Hallandale Beach, FLNPI 1326234279

Payments from drug & device makers

$3,059in general payments, 2019–2025

Across 144 payments — averaging $21.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$644
  • Amgen$451
  • Lilly USA, LLC$296
  • Novo Nordisk$275
  • Scilex Pharmaceuticals Inc.$244
  • Astellas Pharma US Inc$222
  • plus $927 from 16 others

What the payments were for

  • Food & beverage$2,92696%
  • Education$1334%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,059 in reported general payments places this provider in the 80th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Medicare billing

Part B allowed, 2024
$6,837
Medicare patients
24
Services billed
97

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide57$68,061
CreonLipase/Protease/Amylase34$53,327
VascepaIcosapent Ethyl87$33,720
EliquisApixaban40$32,148
OzempicSemaglutide19$25,767
LinzessLinaclotide33$18,465
ProliaDenosumab11$18,271
Repatha SureclickEvolocumab33$18,013
RybelsusSemaglutide14$16,937
TradjentaLinagliptin25$16,283
MounjaroTirzepatide13$15,609
JardianceEmpagliflozin19$13,146
Praluent PenAlirocumab18$8,762
Sucralfate18$7,753
JentaduetoLinagliptin/Metformin Hcl12$5,939

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$296$83,67070 claims
AbbVieCreon, Linzess, Synthroid$644$74,981123 claims
Novo NordiskOzempic, Rybelsus$275$42,70433 claims
PfizerEliquis$72$32,14840 claims
AmgenProlia$451$18,27111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Hallandale Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →